HFE gene mutations increase the risk of coronary heart disease in women

The purpose of the present study is to examine HFE gene mutations in relation to newly diagnosed (incident) coronary heart disease (CHD). In a population-based follow-up study of 7,983 individuals aged 55 years and older, we compared the risk of incident CHD between HFE carriers and non-carriers, ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Pardo Silva, M. Carolina, Njajou, Omer T., Alizadeh, Behrooz Z., Hofman, Albert, Witteman, Jacqueline C. M., van Duijn, Cornelia M., Janssens, A. Cecile J. W.
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2010
Materias:
Genetic Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931632/
https://www.ncbi.nlm.nih.gov/pubmed/20640879
http://dx.doi.org/10.1007/s10654-010-9489-6
Descripción
Sumario:The purpose of the present study is to examine HFE gene mutations in relation to newly diagnosed (incident) coronary heart disease (CHD). In a population-based follow-up study of 7,983 individuals aged 55 years and older, we compared the risk of incident CHD between HFE carriers and non-carriers, overall and stratified by sex and smoking status. HFE mutations were significantly associated with an increased risk of incident CHD in women but not in men (hazard ratio [HR] for women = 1.7, 95% confidence interval [CI] 1.2–2.4 versus HR for men = 0.9, 95% CI 0.7–1.2). This increased CHD risk associated with HFE mutations in women was statistically significant in never smokers (HR = 1.8, 95% CI 1.1–2.8) and current smokers (HR = 3.1, 95% CI 1.4–7.1), but not in former smokers (HR = 1.3, 95% CI 0.7–2.4). HFE mutations are associated with increased risk of incident CHD in women.

Ejemplares similares